Multivariate methods in pharmaceutical applications

Journal of Chemometrics

Volumn 16, Issue 3, 2002, Pages 141-160

  Gabrielsson, Jon ^a   Lindberg, Nils Olof ^b   Lundstedt, Torbjörn ^c,d  

^a UMEÅ UNIVERSITY   (Sweden)

^b PFIZER INC   (United States)

^c Melacure Therapeutics AB   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Design; Multivariate methods; Pharmaceutical applications

Indexed keywords

CONTROLLED DRUG DELIVERY; DATA HANDLING; INFORMATION ANALYSIS; MULTIVARIANT ANALYSIS; PUBLISHING;

COVER MATERIALS; DESIGN APPLICATIONS; DESIGN OPTIMIZATION; EXPERIMENTAL APPLICATION; EXPERIMENTAL OPTIMIZATION; FACTORIAL DESIGN; MULTIVARIATE DATA ANALYSIS; MULTIVARIATE METHODS; MULTIVARIATE TECHNIQUES; PHARMACEUTICAL APPLICATIONS;

STATISTICS;

DATA ANALYSIS; FACTORIAL ANALYSIS; HARDNESS; MULTIVARIATE ANALYSIS; PHARMACY; PUBLICATION; REVIEW;

EID: 0036080082     PISSN: 08869383     EISSN: None     Source Type: Journal    
DOI: 10.1002/cem.697     Document Type: Review

References (105)

1. Simultaneous optimization of multiple criteria in tablet formulation: Part I
2. Simultaneous optimization of multiple criteria in tablet formulation: Part II
3. Application of multivariate analysis in pharmaceutical development work
4. The design of optimum multifactorial experiments
5. Mixture design - Design generation, PLS analysis, and model usage
6. Experimental design and optimization
7. Uniform shell designs
8. Principal component analysis
9. The collinearity problem in linear regression. The partial least squares approach to generalized inverses
10. 31P NMR and a biological duration test for batch approval
11. Multivariate design
12. Use of statistical experimental design in the further development of a discriminating in vitro release test for ethyl cellulose ER-coated spheres of remoxipride
13. Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization
14. Influence of the process parameters on the characteristics of starch based hot stage extrudates
15. Contribution of process variables to the entrapment efficiency of propranolol hydrochloride within ethylcellulose microspheres prepared by the solvent evaporation method as evaluated using a factorial design
16. Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design
17. Factors influencing the encapsulation of thioguanine in DRV liposomes
18. Emulsion formulations: Study of the influence of parameters with experimental designs
19. Oxidation of human insulin-like growth factor I in formulation studies. 3. Factorial experiments of the effects of ferric ions, EDTA, and visible light on methionine oxidation and covalent aggregation in aqueous solution
20. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor
21. Application of classical experimental design for the development of theophylline microspheres
22. Effect of process variables on roller-compacted ibuprofen tablets
23. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization
24. The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design
25. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables
26. Development and in vitro evaluation of nitrendipine transdermal formulations using experimental design techniques
27. Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design
28. Optimization of a reconstitutable suspension of rifampicin using 24 factorial design
29. Formulation of artemisinin tablets
30. Fractional factorial designs for optimizing experimental conditions for Hiestand's indices of tableting performance
31. Experimentally designed optimization of direct compression tablets
32. Atenolol gastrointestinal therapeutic system. I. Screening of formulation variables
33. Aqueous based polymeric dispersion: Plackett-Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system
34. Plackett-Burman screening of micromatrices with polymer mixtures for controlled delivery
35. The effect of formulation parameters on the size of poly-((2-dimethylamino)ethyl methacrylate)-plasmid complexes
36. Response surface method as an approach to optimization of iontophoretic transdermal delivery of pilocarpine
37. An application of the computer optimization technique to wet granulation process involving explosive growth of particles
38. Optimization of HSA and NGF encapsulation yields in PLGA microparticles
39. A systematic formulation optimization process for a generic pharmaceutical tablet
40. Optimization of aqueous-based film coating of tablets performed by a side-vented pancoating system
41. Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling
42. Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheres
43. Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlation
44. Optimization of hydrophilic matrix tablets using a D-optimal design
45. Experimental design for a pharmaceutical formulation: Optimisation and robustness
46. Studies on the in-vitro percutaneous penetration of indomethacin from gel systems in hairless mice
47. A statistical experimental approach to cosolvent formulation of a water-insoluble drug
48. Nonclassical experimental design applied in the optimization of a placebo granulate formulation in high-shear mixer
49. Mixture experimental design applied to solubility predictions
50. Crushing strength, disintegration time and weight variation of tablets compressed from three Avicel® PH grades and their mixtures
51. Simplex-centroid design with surfactant mixture
52. Optimization with experimental design of nonionic, anionic, and amphoteric surfactants in a mixed system
53. A mixture experiment approach for controlling the dissolution rate of a sustained-release tablet
54. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method
55. Mixture experiments with the oil phase of parenteral emulsions
56. Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers
57. A four-component study for estimating solubilities of a poorly soluble compound in multisolvent systems using a Scheffé-type model
58. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer
59. Bioadhesive matrix as controlled release dosage form for verapamil hydrochloride. Effect of mixing polymers on water uptake of the matrix and the drug release rate using simplex lattice design
60. Modeling the effects of hydroxypropylcellulose in acetaminophen tablet formulation
61. Dissolution enhancement of an insoluble drug by physical mixture with a super-disintegrant: Optimization with simplex lattice design
62. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design
63. Formulation design and optimization of modified-release microspheres of diclofenac sodium
64. Oil-in-water-emulsion gels: Determination and mathematical treatment of flow properties
65. Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles
66. Statistical approach to optimization of the drying conditions for a transdermal delivery system
67. Experimental design for a granulation process with 'a priori' criteria
68. Optimization of propranolol hydrochloride sustained release pellets using a factorial design
69. Evaluation of ethylcellulose-coated pellets optimized using the approach of Taguchi
70. Optimization of the processing of matrix pellets based on the combination of waxes and starch using experimental design
71. Optimization of the granulation process for designing tablets
72. Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique
73. Statistical experimental design based studies on placebo and mitoxantrone-loaded albumin microspheres
74. Optimization of an effervescent tablet formulation containing spray dried L-leucine and polyethylene glycol 6000 as lubricants using a central composite design
75. Optimization of a granulation procedure for a hydrophilic matrix tablet using experimental design
76. Identification of factors affecting preservative efficacy and chemical stability of lamivudine oral solution through statistical experimental design
77. Effect of the formulation parameters on the characteristics of pellets
78. Optimization of a new filler/binder for direct compression using central composite design
79. Simultaneous optimization of wet granulation process involving factor of drug content dependency on granule size
80. Box-Behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures
81. Optimization of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability function
82. Optimisation of the composition and production of mannitol/microcrystalline cellulose tablets
83. Statistical optimization of ketoprofen-Eudragit® S100 coprecipitates to obtain controlled-release tablets
84. Design and optimization of theophylline pellets obtained by wet spheronization in a high-shear mixer
85. Preparation and optimization of L-leucine as lubricant for effervescent tablet formulations
86. The combination of factorial design and simplex method in the optimization of lubricants for effervescent tablets
87. Use of canonical and other analyses for the optimization of an extrusion-spheronization process for indomethacin
88. Doehlert experimental design applied to optimization and quality control of a granulation process in a high shear mixer
89. Vergleich von schmiermitteln für brausetabletten mittels hauptkom-ponentenanalyse
90. Evaluation by a statistically designed experiment of an experimental grade of microcrystalline cellulose, Avicel 955, as a technology to aid the production of pellets with high drug loading
91. Investigations of tablets prepared from pellets produced by extrusion and spheronisation. Part I: The application of canonical analysis to correlate the properties of the tablets to the factors studied in combination with principal component analysis to select the most relevant factors
92. Investigations of tablets prepared from pellets produced by extrusion and spheronisation. II. Modelling the properties of the tablets produced using regression analysis
93. Investigation of the effect of type and source of microcrystalline cellulose on capsule filling
94. Multivariate data analysis of variables influencing the dissolution rate of prednimustine: A case of disconformity with the Noyes-Whitney equation
95. Optimization of crushing strength and disintegration time of a high-dose plant extract tablet by neural networks
96. Dissolution rates of different drugs from solid dispersions with Eudragit RS
97. Accelerated dissolution rate analysis (ACDRA) for controlled release drugs. Application to Roxiam®
98. Multivariate modelling of the tablet manufacturing process with wet granulation for tablet optimization and in-process control
99. Oxidation of human insulin-like growth factor I in formulation studies. II. Effects of oxygen, visible light, and phosphate on methionine oxidation in aqueous solution and evaluation of possible mechanisms
100. A multivariate method to predict the water vapour diffusion rate through polypropylene packaging
101. An opportunistic stability strategy; simulation with real data
102. Multivariate methods in developing an evolutionary strategy for tablet formulation